You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Company Profile

Boehringer Ingelheim in Consumer Health

Sep 2011

Price: US$525

About this Report

About this Report

Euromonitor International's report on Boehringer Ingelheim GmbH delivers a detailed strategic analysis of the company's business, examining its performance in the Vitamins and Dietary Supplements market and the global economy.

Company and market share data provide a detailed look at the financial position of Boehringer Ingelheim GmbH, while in-depth qualitative analysis will help you understand the brand strategy and growth prospects of Boehringer Ingelheim GmbH This report examines:

  • Company share by region and sector
  • Brand portfolio
  • New product developments
  • Marketing and distribution strategies

A detailed SWOT analysis of Boehringer Ingelheim GmbH provides strategic intelligence on:

  • Strengths and weaknesses
  • Category and country opportunities for growth
  • Challenges and threats from current competition and future prospects
  • Global and regional market positions

Research You Can Trust

Euromonitor International's company profile reports are written by our Vitamins and Dietary Supplements research team, a dedicated group of analysts that knows the industry inside and out.

Buy this report to inform your planning, strategy, marketing, sales and competitor intelligence functions.

Delivery:
Reports are delivered in pdf format and can be downloaded from your online account (called My Pages) immediately after purchase.

Table of Contents

Table of Contents

Scope of the Report

Scope

  • Scope of the Report

Strategic Evaluation

Key company facts

  • Strategic Evaluation

Expansion of key brands helps drive consumer health

  • Strategic Evaluation

SWOT: Boehringer Ingelheim GmbH

  • Strategic Evaluation

Key strategic objectives and challenges

  • Strategic Evaluation

Competitive Positioning

Digestive remedies and analgesics dominate performance

  • Competitive Positioning

Consumer health remains fragmented

  • Competitive Positioning

Cough, cold and allergy remedies crucial for Boehringer

  • Competitive Positioning

Reliance on Japan may hurt Boehringer

  • Competitive Positioning

Geographic Opportunities

Strength in Brazil: weakness in China

  • Geographic Opportunities

Declining category sales and production interruptions

  • Geographic Opportunities

Select opportunities in Japan at product level

  • Geographic Opportunities

PPI presents direct threat to H2 blockers in mature markets

  • Geographic Opportunities

Focus on cough remedies means loss of opportunities

  • Geographic Opportunities

Create umbrella brand in analgesics

  • Geographic Opportunities

Pharmaton : Boehringer flagship brand

  • Geographic Opportunities

Product Opportunities

PPI: where to launch

  • Product Opportunities

A view on PPI

  • Product Opportunities

Consider Antistax for additional backing in new markets

  • Product Opportunities

Look to expand beyond cough remedies

  • Product Opportunities

Brand and Private Label Strategy

Multivitamin focus and lack of regional diversity

  • Brand and Private Label Strategy

Mucosolvan : Boehringer strength in cough remedies

  • Brand and Private Label Strategy

Buscopan : educating public on IBS treatment

  • Brand and Private Label Strategy

Operations

Research and development , production and distribution

  • Operations

Recommendations

Key recommendations

  • Recommendations

Samples

Please update/install flash.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!